Circulating tumor cells as an early detection tool for BRCA positive women?
Georg Pfeiler(Medical University of Vienna), Tanja Fehm(Düsseldorf University Hospital), Christian F. Singer(Comprehensive Cancer Center Vienna), Zsuzsanna Bagó-Horváth(Comprehensive Cancer Center Vienna), Margaretha Rudas(Comprehensive Cancer Center Vienna), Alex Farr(Medical University of Vienna), Thomas H. Helbich(Vienna General Hospital), Muy‐Kheng M. Tea(Medical University of Vienna), Maria Bernathova(Medical University of Vienna)
Cited by 0
Related Papers
ESMO Clinical Practice Guideline for the diagnosis, staging and treatment of patients with metastatic breast cancer
|Annals of Oncology|2021|1.4k
Stand-Alone Artificial Intelligence for Breast Cancer Detection in Mammography: Comparison With 101 Radiologists
|JNCI Journal of the National Cancer Institute|2018|674
Overall survival in the OlympiA phase III trial of adjuvant olaparib in patients with germline pathogenic variants in BRCA1/2 and high-risk, early breast cancer
|Annals of Oncology|2022|461